Atlas Trials

Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy

Clinical trial NCT07528716 · RECRUITING

Trial details

NCT number
NCT07528716
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2026-05-06
Primary completion
2027-12-01
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.